Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Bleeding and thrombotic events are an emerging toxicity associated with chimeric antigen receptor (CAR) therapies. To determine their incidence, we retrospectively analyzed consecutive adult patients (N = 127) with large B-cell lymphoma (LBCL) or B-cell acute lymphoblastic leukemia (B-ALL) treated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnsrud, Andrew, Craig, Juliana, Baird, John, Spiegel, Jay, Muffly, Lori, Zehnder, James, Tamaresis, John, Negrin, Robert, Johnston, Laura, Arai, Sally, Shizuru, Judith, Lowsky, Robert, Meyer, Everett, Weng, Wen-Kai, Shiraz, Parveen, Rezvani, Andrew, Latchford, Theresa, Mackall, Crystal, Miklos, David, Frank, Matthew, Sidana, Surbhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579267/
https://www.ncbi.nlm.nih.gov/pubmed/34521106
http://dx.doi.org/10.1182/bloodadvances.2021004716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579267/
https://www.ncbi.nlm.nih.gov/pubmed/34521106
http://dx.doi.org/10.1182/bloodadvances.2021004716

Ejemplares similares